Lower Levels Of Pro-Inflammatory Immune Signaling Proteins Found In Blood Of People With RRMS Treated With Natalizumab, Study Indicates
November 25, 2020
Multiple Sclerosis News Today (11/24, Bryson) reports researchers found “lower levels of pro-inflammatory immune signaling proteins were found in the blood of people with relapsing-remitting multiple sclerosis (RRMS) treated with Tysabri (natalizumab) and...